C4 Therapeutics, Inc. (CCCC): Weighted Average Diluted Shares
82.89M
Year ended 2025-12-31
+19.3%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 82.89M | +19.5% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | 69.37M | +39.8% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | 49.64M | +1.6% | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | 48.86M | +6.1% | 2024-02-22, From 2022-01-01 |
| 2021-12-31 | 46.04M | n/a | 2023-02-23, From 2021-01-01 |